SPAC Overview
$40M
IPO Size
$42.8M
Trust (as of 2014-12-18)
Failed
Current Status
2014
IPO Year
Timeline Progress
About
CB Pharma Acquisition Corp. is a blank-check company formed to combine with an unidentified business. Its initial search focus is specialty pharma and generic drug industries, including drug rights or companies holding such rights.
Investment Focus
Biopharmaceuticals
Geographic Focus
North America, Europe, South America, Asia
The terms and the filing trail behind CB Pharma Acquisition Corp.
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Extended Team Information
Led by Lindsay A. Rosenwald, a life-sciences investment and pharmaceutical executive, and Michael S. Weiss, a biotechnology executive and investor; other directors bring biologics operations, investment, legal, finance and clinical medicine experience.
Key Information
IPO Date
December 12, 2014
Total Redemptions
$3M
State of Incorporation
E9
SIC
6770
Failed Date
November 15, 2018
SPAC Ticker
CNLM